Surgical treatment of juvenile nasopharyngeal angiofibroma
Грачев Н. С., Ворожцов И. Н., Фролов С. В., Полев Г. А.
Педиатрия. Журнал им. Г.Н. Сперанского
Т. 98, Вып. 4, С. 205-209
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.24110/0031-403X-2019-98-4-205-209
Аннотация:
Juvenile angiofibroma (JA) is a benign vascular tumor that is diagnosed based on clinical symptoms and X-ray data. It is characterized by a specific type of distribution, in most cases involving the pterygopalatine fossa and base of pterygoid process of the sphenoid. The main treatment for JA is surgical removal, while radiation therapy remains the method of choice for relapses and unresectable tumors. Currently, endoscopic transnasal surgery is considered the leading treatment method for JA. It is applicable to common tumors, but should only be performed by surgical centers with extensive experience. © 2019, Pediatria Ltd.. All rights reserved.
Ключевые слова:
Endoscopic transnasal surgery; Juvenile nasopharyngeal angiofibroma; Pterygopalatine fossa
palivizumab; Article; congenital heart disease; drug efficacy; drug safety; drug tolerance; endoscopy; heart disease; hemodynamics; high risk population; hospitalization; human; Human respiratory syncytial virus; immunization; infant; lower respiratory tract; lung dysplasia; multicenter study; nasopharynx fibroma; prospective study; pterygoid muscle; pterygopalatine fossa; respiratory syncytial virus infection; respiratory tract disease; Russian Federation; sphenoid; vascular tumor; X ray
Язык текста: Русский
ISSN: 1990-2182
Грачев Н. С.
Ворожцов И. Н.
Фролов С. В.
Полев Г. А.
Grachev N. S.
Vorozhtsov I. N.
Frolov S. V.
Polev G. A.
Surgical treatment of juvenile nasopharyngeal angiofibroma
Текст визуальный непосредственный
Педиатрия. Журнал им. Г.Н. Сперанского
ООО "Педиатрия"
Т. 98, Вып. 4 С. 205-209
2019
Статья
Endoscopic transnasal surgery Juvenile nasopharyngeal angiofibroma Pterygopalatine fossa
palivizumab Article congenital heart disease drug efficacy drug safety drug tolerance endoscopy heart disease hemodynamics high risk population hospitalization human Human respiratory syncytial virus immunization infant lower respiratory tract lung dysplasia multicenter study nasopharynx fibroma prospective study pterygoid muscle pterygopalatine fossa respiratory syncytial virus infection respiratory tract disease Russian Federation sphenoid vascular tumor X ray
Juvenile angiofibroma (JA) is a benign vascular tumor that is diagnosed based on clinical symptoms and X-ray data. It is characterized by a specific type of distribution, in most cases involving the pterygopalatine fossa and base of pterygoid process of the sphenoid. The main treatment for JA is surgical removal, while radiation therapy remains the method of choice for relapses and unresectable tumors. Currently, endoscopic transnasal surgery is considered the leading treatment method for JA. It is applicable to common tumors, but should only be performed by surgical centers with extensive experience. © 2019, Pediatria Ltd.. All rights reserved.